An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Open accessThe DOI matches its Crossref record; 324 of the 325 references it cites were found in a registry or an index.
Abstract
This document is an international evidence-based guideline on the diagnosis and management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association. It represents the current state of knowledge regarding idiopathic pulmonary fibrosis (IPF), and contains sections on definition and epidemiology, risk factors, diagnosis, natural history, staging and prognosis, treatment, and monitoring disease course. For the diagnosis and treatment sections, pragmatic GRADE evidence-based methodology was applied in a question-based format. For each diagnosis and treatment question, the committee graded the quality of the evidence available (high, moderate, low, or very low), and made a recommendation (yes or no, strong or weak). Recommendations were based on majority vote. It is emphasized that clinicians must spend adequate time with patients to discuss patients' values and preferences and decide on the appropriate course of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, all patients originally gathered from hospital register using ICD-10 codes were meticulously re-assessed and re-classified using the year 2011 criteria, and the cases representing some other type of ILDs were excluded [14].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ILD still has a poor prognosis and the highest mortality rate during lung transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interstitial lung disease (ILD) remains an important indication for lung transplantation, and the number of patients with this disease is increasing.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Idiopathic pulmonary fibrosis (IPF), characterized histopathologically and/or radiologically with a usual interstitial pneumonia (UIP) pattern, is the most common adult form of interstitial pneumonia of unknown origin [1].”
From Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature (2014) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The median survival time for patients with IPF is 2 to 3 years from diagnosis and the 5-year survival rate ranges between 30% and 50% [1,5-7].”
From Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature (2014) · cites this paper as [1]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C. P. M., Gustafsson, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034805 · Cited by 15,627
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Interpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
Fleischner Society: Glossary of Terms for Thoracic Imaging
Hansell, D. M., Bankier, A. A., MacMahon, H., McLoud, T. C., Müller, N. L., & Remy, J. (2008) · Radiology · doi:10.1148/radiol.2462070712 · Cited by 4,198
Self-citation(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Standardisation of the measurement of lung volumes
Wanger, J., Clausen, J. L., Coates, A., Pedersen, O. F., Brusasco, V., Burgos, F., Casaburi, R., Crapo, R., Enright, P., van der Grinten, C. P. M., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035005 · Cited by 2,768
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Standardisation of the single-breath determination of carbon monoxide uptake in the lung
MacIntyre, N., Crapo, R. O., Viegi, G., Johnson, D. C., van der Grinten, C. P. M., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Enright, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034905 · Cited by 2,255
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
Research works printed but not linked: 9
- Cochrane Handbook for Systematic Reviews of Interventions 5.0.2. Oxford: The Cochrane Collaboration, 2009. [online] 2009. [accessed 20 June 2010]; Available from: http://www.cochrane.org/resources/handbook/.
- Nadrous HF, Ryu JH, Douglas WW, Decker PA, Olson EJ. Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis. Chest 2004;126:438–446. [DOI] [PubMed] [Google Scholar]
- 2005, J Gastrointest Surg, 1053
- Marshall RP, Puddicombe A, Cookson WO, Laurent GJ. Adult familial cryptogenic fibrosing alveolitis in the UK. Thorax 2000;55:143–146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345:517–525. [DOI] [PubMed] [Google Scholar]
- Kondo A, Saiki S. Acute exacerbation in idiopathic interstitial pneumonia (IIP). In: Harasawa M, Fukuchi Y, Morinari H, editors. Interstitial pneumonia of unknown etiology. Tokyo: University of Tokyo Press; 1989. pp. 33–42.
- Flaherty KR, Colby TV, Toews GB, Travis WD, Flint A, Gay SE, Strawderman RL III, Jain A, Lynch JP III, Martinez FJ. Differential presence of fibroblastic foci in UIP patients with or without conntective tissue disease. Am J Respir Crit Care Med 2001;163:A983. [Google Scholar]
- Molina-Molina M, Badia JR, Marin-Arguedas A, Xaubet A, Santos MJ, Nicolas JM, Ferrer M, Torres A. Outcomes and clinical characteristics of patients with pulmonary fibrosis and respiratory failure admitted to an intensive care unit: a study of 20 cases. Med Clin (Barc) 2003;121:63–67. [DOI] [PubMed] [Google Scholar]
- Pitsiou G, Ioannis Trigonis I, Tsiata E, Kontou P, Manolakoglou N, Stanopoulos I, Mavrofridis E, Argyropoulou P. Outcome of patients with pulmonary fibrosis admitted to the ICU for acute respiratory failure. Eur Respir J Suppl 2006;28:E650. [Google Scholar]
Cited by
Items 801–900 of 1,060
Regulation of TGF-β storage and activation in the human idiopathic pulmonary fibrosis lung
Leppäranta, O., Sens, C., Salmenkivi, K., Kinnula, V. L., Keski‐Oja, J., Myllärniemi, M., & Koli, K. M. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1385-9 · Cited by 92
A Primer on Interstitial Lung Disease and Thoracic Radiation
Goodman, C. D., Nijman, S. F. M., Senan, S., Nossent, E. J., Ryerson, C. J., Dhaliwal, I., Qu, X. M., Laba, J. M., Rodrigues, G., & Palma, D. A. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.02.005 · Cited by 92
The role of microRNAs in chronic respiratory disease: recent insights
Stolzenburg, L. R., & Harris, A. (2017) · Biological Chemistry · doi:10.1515/hsz-2017-0249 · Cited by 92
High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study
Desai, S. R., Sivarasan, N., Johannson, K. A., George, P. M., Culver, D. A., Devaraj, A., Lynch, D. A., Milne, D. G., Renzoni, E. A., Nunès, H., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00267-9 · Cited by 92
Self-citationYamaguchi, M., Hirai, S., Tanaka, Y., Sumi, T., Miyajima, M., Mishina, T., Yamada, G., Otsuka, M., Hasegawa, T., Kojima, T., et al. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.135 · Cited by 92
BAFF-driven B cell hyperplasia underlies lung disease in common variable immunodeficiency
Maglione, P. J., Gyimesi, G., Cols, M., Radigan, L., Ko, H. M., Weinberger, T., Lee, B. H., Grasset, E. K., Rahman, A. H., Cerutti, A., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.122728 · Cited by 92
Hozumi, H., Enomoto, N., Kono, M., Fujisawa, T., Inui, N., Nakamura, Y., Sumikawa, H., Johkoh, T., Nakashima, R., Imura, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120313 · Cited by 92
Self-citationLung transplantation for interstitial lung disease
Kapnadak, S. G., & Raghu, G. (2021) · European Respiratory Review · doi:10.1183/16000617.0017-2021 · Cited by 91
Self-citationGenetics and Early Detection in Idiopathic Pulmonary Fibrosis
Putman, R. K., Rosas, I. O., & Hunninghake, G. M. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2219pp · Cited by 91
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease
Ferri, C., Manfredi, A., Sebastiani, M., Colaci, M., Giuggioli, D., Vacchi, C., Casa, G. D., Cerri, S., Torricelli, P., & Luppi, F. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.09.003 · Cited by 91
Long‐term outcomes in chronic hypersensitivity pneumonitis
Ojanguren, Í., Morell, F., Ramón, M. A., Villar, A., Mesones, C. E. R., Cruz, M. J., & Muñoz, X. (2019) · Allergy · doi:10.1111/all.13692 · Cited by 91
Procedure volume and mortality after surgical lung biopsy in interstitial lung disease
Fisher, J. H., Shapera, S., To, T. M., Marras, T. K., Gershon, A. S., & Dell, S. (2019) · European Respiratory Journal · doi:10.1183/13993003.01164-2018 · Cited by 91
Mermigkis, C. M., Bouloukaki, I., Antoniou, K. M., Mermigkis, D., Psathakis, K., Giannarakis, I., Varouchakis, G., Siafakas, N. M., & Schiza, S. E. (2013) · Sleep And Breathing · doi:10.1007/s11325-013-0813-8 · Cited by 91
Gaikwad, A. V., Eapen, M. S., McAlinden, K. D., Chia, C., Larby, J., Myers, S., Dey, S., Haug, G., Markos, J., Glanville, A. R., et al. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1795832 · Cited by 91
Update in diagnosis and management of interstitial lung disease
Mikolasch, T., Garthwaite, H. S., & Porter, J. C. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-6-s71 · Cited by 91
Hypoxia enhances IPF mesenchymal progenitor cell fibrogenicity via the lactate/GPR81/HIF1α pathway
Yang, L., Gilbertsen, A. J., Hong, X., Benyumov, A. O., Smith, K., Herrera, J., Racila, E. V., Bitterman, P. B., & Henke, C. A. (2023) · JCI Insight · doi:10.1172/jci.insight.163820 · Cited by 91
Surgical Lung Biopsy for Interstitial Lung Diseases
Raj, R., Raparia, K., Lynch, D. A., & Brown, K. M. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.06.019 · Cited by 91
Self-citationRadiological Diagnosis in Lung Disease
Wielpütz, M. O., Heußel, C. P., Herth, F. J. F., & Kauczor, H. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0181 · Cited by 91
Chronic Hypersensitivity Pneumonitis With a Usual Interstitial Pneumonia-Like Pattern
Chiba, S., Tsuchiya, K., Akashi, T., Ishizuka, M., Okamoto, T., Furusawa, H., Tateishi, T., Kishino, M., Miyazaki, Y., Tateishi, U., et al. (2016) · CHEST Journal · doi:10.1016/j.chest.2015.12.030 · Cited by 91
Current approaches to the management of idiopathic pulmonary fibrosis
Raghu, G., & Richeldi, L. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.05.017 · Cited by 90
Self-citationThe Role of TGF-β Signaling in Lung Cancer Associated with Idiopathic Pulmonary Fibrosis
Saito, A., Horie, M., Micke, P., & Nagase, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113611 · Cited by 90
Alveolar cells under mechanical stressed niche: critical contributors to pulmonary fibrosis
Yang, J., Pan, X., Wang, L., & Yu, G. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00223-w · Cited by 90
Swigris, J. J., Esser, D., Conoscenti, C. S., & Brown, K. K. (2014) · Health and Quality of Life Outcomes · doi:10.1186/s12955-014-0124-1 · Cited by 90
Self-citationCurrent and novel drug therapies for idiopathic pulmonary fibrosis
Maher, T. M., & Adamali, H. I. (2012) · Drug Design Development and Therapy · doi:10.2147/dddt.s29928 · Cited by 90
Rivera‐Ortega, P., Hayton, C., Blaikley, J., Leonard, C. T., & Chaudhuri, N. (2018) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466618800618 · Cited by 90
Regulation and Relevance of Myofibroblast Responses in Idiopathic Pulmonary Fibrosis
Moore, M. W., & Herzog, E. L. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0017-8 · Cited by 90
Cox, I. A., Arriagada, N. B., de Graaff, B., Corte, T. J., Glaspole, I., Lartey, S. T., Walters, E. H., & Palmer, A. J. (2020) · European Respiratory Review · doi:10.1183/16000617.0154-2020 · Cited by 90
Bhat, A. A., Afzal, M., Goyal, A., Gupta, G., Thapa, R., Almalki, W. H., Kazmi, I. A., Alzarea, S. I., Shahwan, M. J., Paudel, K. R., et al. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111002 · Cited by 90
The diagnosis and management of interstitial lung diseases
Wallis, A., & Spinks, K. (2015) · BMJ · doi:10.1136/bmj.h2072 · Cited by 90
Hilberg, O., Hoffmann‐Vold, A., Smith, V. M., Bouros, D. E., Kilpeläinen, M., Guiot, J., Morais, A., Clemente, S., Daniil, Z. D., Papakosta, D., et al. (2021) · ERJ Open Research · doi:10.1183/23120541.00597-2021 · Cited by 90
Self-citationKatzenstein, A.-L. A. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.154 · Cited by 90
Tang, J., Li, J., Guo, L., Zhang, H., Wang, L., Li, D., & Ding, J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s140569 · Cited by 90
Desmoplakin variants are associated with idiopathic pulmonary fibrosis
Mathai, S. K., Pedersen, B. S., Smith, K., Russell, P., Schwarz, M. I., Brown, K. K., Steele, M. P., Loyd, J. E., Crapo, J. D., Silverman, E. K., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201509-1863oc · Cited by 89
Self-citationEmerging delivery approaches for targeted pulmonary fibrosis treatment
Diwan, R., Bhatt, H., Beaven, E., & Nurunnabi, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115147 · Cited by 89
Ma, X., Zhu, L., Kurche, J. S., Xiao, H., Dai, H., & Wang, C. (2020) · Thorax · doi:10.1136/thoraxjnl-2020-216732 · Cited by 89
Chest CT Features are Associated With Poorer Quality of Life in Acute Lung Injury Survivors*
Burnham, E. L., Hyzy, R. C., Paine, R., Coley, C., Kelly, A. M., Quint, L. E., Lynch, D., Janssen, W. J., Moss, M., & Standiford, T. J. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31826a5062 · Cited by 89
Self-citationIdiopathic Pulmonary Fibrosis: Treatment and Prognosis
Fujimoto, H., Kobayashi, T., & Azuma, A. (2015) · Clinical Medicine Insights Circulatory Respiratory and Pulmonary Medicine · doi:10.4137/ccrpm.s23321 · Cited by 89
Zhao, H., Bian, H., Bu, X., Zhang, S., Zhang, P., Yu, J., Lai, X., Li, D., Zhu, C., Yao, L., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.109 · Cited by 89
Jacob, J., Bartholmai, B. J., Rajagopalan, S., Kokosi, M. A., Egashira, R., Brun, A., Nair, A., Walsh, S. L. F., Karwoski, R. A., & Wells, A. U. (2017) · European Radiology · doi:10.1007/s00330-017-5053-z · Cited by 89
Self-citationd’Alessandro, M., Bergantini, L., Cameli, P., Vietri, L., Lanzarone, N., Alonzi, V., Pieroni, M., Refini, R. M., Sestini, P., Bonella, F., et al. (2020) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0545 · Cited by 89
Cameli, P., Refini, R. M., Bergantini, L., d’Alessandro, M., Alonzi, V., Magnoni, C., Rottoli, P., Sestini, P., & Bargagli, E. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.581828 · Cited by 89
Chen, Y.-L., Zhang, X., Bai, J., Gai, L., Xl, Y., Zhang, L., Xu, Q., Yx, Z., Xu, L., Li, H., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.154 · Cited by 89
miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II
Zhang, Q., Ye, H., Xiang, F., Song, L.-J., Zhou, L.-L., Cai, P., Zhang, J.-C., Fan, Y., Shi, H., Su, Y., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.12.017 · Cited by 89
Unclassifiable interstitial lung disease: A review
Skolnik, K., & Ryerson, C. J. (2015) · Respirology · doi:10.1111/resp.12568 · Cited by 89
Current best practice in rehabilitation in interstitial lung disease
Nakazawa, A., Cox, N. S., & Holland, A. E. (2016) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465816676048 · Cited by 89
Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis
Takahashi, Y., Saito, A., Chiba, H., Kuronuma, K., Ikeda, K., Kobayashi, T., Ariki, S., Takahashi, M., Sasaki, Y., & Takahashi, H. (2018) · Respiratory Research · doi:10.1186/s12931-018-0736-9 · Cited by 89
Mesenchymal Stem Cell Trials for Pulmonary Diseases
Antunes, M. A., Laffey, J. G., Pelosi, P. P., & Rocco, P. R. M. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24783 · Cited by 89
Lindell, K. O., Kavalieratos, D., Gibson, K. F., Moreines, L. T., & Rosenzweig, M. Q. (2016) · Heart & Lung · doi:10.1016/j.hrtlng.2016.10.002 · Cited by 89
Lung Cancer in Combined Pulmonary Fibrosis and Emphysema: A Systematic Review and Meta-Analysis
Koo, H. J., Do, K., Lee, J. B., Alblushi, S., & Lee, S. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161437 · Cited by 89
Respiratory muscle function in interstitial lung disease
Walterspacher, S., Schlager, D., Walker, D., Müller–Quernheim, J., Windisch, W., & Kabitz, H. (2012) · European Respiratory Journal · doi:10.1183/09031936.00109512 · Cited by 89
Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis
Minai, O. A., Santacruz, J. F., Alster, J. M., Budev, M. M., & McCarthy, K. J. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.07.013 · Cited by 89
Matteson, E. L., Bongartz, T., Ryu, J. H., Crowson, C. S., Hartman, T. E., & Dellaripa, P. F. (2012) · Open Journal of Rheumatology and Autoimmune Diseases · doi:10.4236/ojra.2012.23011 · Cited by 89
Self-citationLi, F., Zhou, Z., Wu, A., Cai, Y., Wu, H., Chen, M., & Liang, S. (2018) · Radiation Oncology · doi:10.1186/s13014-018-1030-1 · Cited by 89
Bai, L., Bernard, K., Tang, X., Hu, M., Horowitz, J. C., Thannickal, V. J., & Sanders, Y. Y. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0180oc · Cited by 88
Åhrman, E., Hallgren, O., Malmström, L., Hedström, U., Malmström, A., Bjermer, L., Zhou, X.-H., Westergren-Thorsson, G., & Malmström, J. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.02.027 · Cited by 88
O'Dwyer, D. N., Ashley, S. L., & Moore, B. B. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00221.2016 · Cited by 88
Park, H. J., Lee, S. M., Song, J. W., Lee, S. M., Oh, S. Y., Kim, N., & Seo, J. B. (2016) · American Journal of Roentgenology · doi:10.2214/ajr.16.16054 · Cited by 88
Mai, C., Verleden, S. E., McDonough, J. E., Willems, S., Wever, W. D., Coolen, J., Dubbeldam, A., Raemdonck, D. E. V., Verbeken, E. K., Verleden, G. M., et al. (2016) · Radiology · doi:10.1148/radiol.2016152362 · Cited by 88
Moor, C. C., Wapenaar, M., Miedema, J. R., Geelhoed, J. J. M., Chandoesing, P. P., & Wijsenbeek, M. S. (2018) · Respiratory Research · doi:10.1186/s12931-018-0810-3 · Cited by 88
Jee, A. S., Adelstein, S., Bleasel, J. F., Keir, G. J., Nguyen, M., Sahhar, J., Youssef, P. P., & Corte, T. J. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6050051 · Cited by 88
Kurundkar, A., Kurundkar, D., Rangarajan, S., Locy, M. L., Zhou, Y., Liu, R.-M., Zmijewski, J. W., & Thannickal, V. J. (2016) · The FASEB Journal · doi:10.1096/fj.201500173 · Cited by 88
Management of suspected monogenic lung fibrosis in a specialised centre
Borie, R., Kannengiesser, C., de Fontbrune, F. S., Gouya, L., Nathan, N., & Crestani, B. (2017) · European Respiratory Review · doi:10.1183/16000617.0122-2016 · Cited by 88
Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis
Fabrellas, E. F., Sánchez, R. P., Abad, C. S., & Samper, G. J. (2018) · Medical Sciences · doi:10.3390/medsci6020051 · Cited by 88
Kondoh, Y., Taniguchi, H., Ebina, M., Azuma, A., Ogura, T., Taguchi, Y., Suga, M., Takahashi, H., Nakata, K., Sugiyama, Y., et al. (2015) · Respiratory Investigation · doi:10.1016/j.resinv.2015.04.005 · Cited by 88
Self-citationManfredi, A., Sebastiani, M., Cerri, S., Cassone, G., Bellini, P., Casa, G. D., Luppi, F., & Ferri, C. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3601-1 · Cited by 88
Arthritis), O. B. O. G. (. I. S. E., Manfredi, A., Cassone, G., Cerri, S., Venerito, V., Fedele, A. L., Trevisani, M., Furini, F., Addimanda, O., Pancaldi, F., et al. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0875-x · Cited by 88
Nonintubated thoracoscopic surgery: state of the art and future directions.
Hung, M., Hsu, H., Cheng, Y., & Chen, J. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2014.01.16 · Cited by 88
Doubková, M., Švancara, J., Svoboda, M., Šterclová, M., Bartoš, V., Plačková, M., Lacina, L., Žurková, M., Binková, I., Bittenglová, R., et al. (2018) · The Clinical Respiratory Journal · doi:10.1111/crj.12700 · Cited by 87
Fat‐free mass index predicts survival in patients with idiopathic pulmonary fibrosis
Nishiyama, O., Yamazaki, R., Sano, H., Iwanaga, T., Higashimoto, Y., Kume, H., & Tohda, Y. (2016) · Respirology · doi:10.1111/resp.12941 · Cited by 87
Durheim, M. T., Collard, H. R., Roberts, R. S., Brown, K. K., Flaherty, K. R., King, T. E., Palmer, S. M., Raghu, G., Snyder, L. D., Anstrom, K. J., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00093-4 · Cited by 87
Self-citationRecent advances in understanding idiopathic pulmonary fibrosis
Daccord, C., & Maher, T. M. (2016) · F1000Research · doi:10.12688/f1000research.8209.1 · Cited by 87
Staging of idiopathic pulmonary fibrosis: past, present and future
Kolb, M., & Collard, H. R. (2014) · European Respiratory Review · doi:10.1183/09059180.00002114 · Cited by 87
Self-citationKreuter, M., Bonella, F., Wijsenbeek, M., Maher, T. M., & Spagnolo, P. (2015) · BioMed Research International · doi:10.1155/2015/329481 · Cited by 87
Yoo, H., Jeong, B., Chung, M. J., Lee, K. S., Kwon, O. J., & Chung, M. P. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0905-8 · Cited by 87
Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal
Τzouvelekis, Α., Koliakos, G., Ntolios, P., Baira, I., Bouros, E., Oikonomou, A., Zissimopoulos, A., Kolios, G. C., Kakagia, D. D., Paspaliaris, V., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-182 · Cited by 87
Self-citationGuiot, J., Henket, M., Corhay, J. L., Moermans, C., & Louis, R. (2017) · PLOS ONE · doi:10.1371/journal.pone.0171344 · Cited by 87
Pirfenidone improves survival in IPF: results from a real-life study
Margaritopoulos, G. A., Trachalaki, A., Wells, A. U., Vasarmidi, E., Bibaki, E., Papastratigakis, G., Detorakis, S., Tzanakis, N., & Antoniou, K. M. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0736-z · Cited by 87
Self-citationImpact of idiopathic pulmonary fibrosis on advanced non-small cell lung cancer survival
Kanaji, N., Tadokoro, A., Kita, N., Murota, M., Ishii, T., Takagi, T., Watanabe, N., Tojo, Y., Harada, S., Hasui, Y., et al. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2199-z · Cited by 87
Exosomal miRNAs in Lung Diseases: From Biologic Function to Therapeutic Targets
Guiot, J., Struman, I., Louis, E. J., Louis, R. E., Malaise, M., & Njock, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091345 · Cited by 87
Idiopathic interstitial pneumonias with connective tissue diseases features: A review
Cottin, V. (2015) · Respirology · doi:10.1111/resp.12588 · Cited by 87
Qiu, M., Chen, Y., & Ye, Q. (2017) · The Clinical Respiratory Journal · doi:10.1111/crj.12631 · Cited by 87
Hosoda, C., Baba, T., Hagiwara, E., Ito, H., Matsuo, N., Kitamura, H., Iwasawa, T., Okudela, K., Takemura, T., & Ogura, T. (2016) · Respirology · doi:10.1111/resp.12763 · Cited by 87
Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial
Sakamoto, S., Kataoka, K., Kondoh, Y., Kato, M., Okamoto, M., Mukae, H., Bando, M., Suda, T., Yatera, K., Tanino, Y., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.00348-2020 · Cited by 67
Self-citationCottin, V. (2019) · European Respiratory Review · doi:10.1183/16000617.0109-2019 · Cited by 86
Jacob, J., Song, J. W., Yoon, H., Cross, G., Barnett, J. L., Woo, W. L., Adams, F., Kokosi, M. A., Devaraj, A., Renzoni, E. A., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.01.038 · Cited by 86
Self-citationBonini, M., & Fiorenzano, G. (2017) · European Respiratory Review · doi:10.1183/16000617.0099-2016 · Cited by 86
Implications of the Immune Landscape in COPD and Lung Cancer: Smoking Versus Other Causes
Taucher, E., Mykoliuk, I., Lindenmann, J., & Smolle-Jüettner, F.-M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.846605 · Cited by 86
Survival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach
Papiris, S. A., Kagouridis, K., Kolilekas, L., Papaioannou, A. Ι., Roussou, A., Triantafillidou, C., Baou, K., Malagari, K. S., Argentos, S., Kotanidou, A. N., et al. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0146-4 · Cited by 86
Pleuroparenchymal fibroelastosis diagnosed by multidisciplinary discussions in Japan
Ishii, H., Watanabe, K., Kushima, H., Baba, T., Watanabe, S., Yamada, Y., Arai, T., Tsushima, K., Kondoh, Y., Nakamura, Y., et al. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.06.022 · Cited by 86
Self-citationAutoimmunity to vimentin is associated with outcomes of patients with idiopathic pulmonary fibrosis
Li, F. J., Surolia, R., Li, H., Wang, Z., Kulkarni, T., Liu, G., de Andrade, J. A., Kass, D. J., Thannickal, V. J., Duncan, S. R., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700473 · Cited by 85
Senescent cells and the incidence of age‐related diseases
Katzir, I., Adler, M., Karin, O., Mendelsohn‐Cohen, N., Mayo, A., & Alon, U. (2021) · Aging Cell · doi:10.1111/acel.13314 · Cited by 85
MicroRNA regulatory networks in idiopathic pulmonary fibrosis
Pandit, K. V., & Milosevic, J. (2015) · Biochemistry and Cell Biology · doi:10.1139/bcb-2014-0101 · Cited by 85
Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis
Kreuter, M., Bonella, F., Maher, T. M., Costabel, U., Spagnolo, P., Weycker, D., Kirchgaessler, K.-U., & Kolb, M. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-208819 · Cited by 85
Self-citationThe Increasing Secondary Care Burden of Idiopathic Pulmonary Fibrosis
Navaratnam, V. V., Fogarty, A., Glendening, R., McKeever, T. M., & Hubbard, R. (2013) · CHEST Journal · doi:10.1378/chest.12-0803 · Cited by 85
Localized hypoxia links ER stress to lung fibrosis through induction of C/EBP homologous protein
Burman, A., Kropski, J. A., Calvi, C. L., Serezani, A. P., Pascoalino, B. D., Han, W., Sherrill, T., Gleaves, L., Lawson, W. E., Young, L. R., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99543 · Cited by 85
Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis
Murray, L. A., Habiel, D. M., Hohmann, M., Camelo, A., Shang, H., Zhou, Y., Coelho, A. L., Peng, X., Gulati, M., Crestani, B., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92192 · Cited by 85
Sibinska, Z., Tian, X., Korfei, M., Kojonazarov, B., Kolb, J. S., Klepetko, W., Kosanovic, D., Wygrecka, M., Ghofrani, H. A., Weissmann, N., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01941-2015 · Cited by 85
Development and validation of a radiological diagnosis model for hypersensitivity pneumonitis
Salisbury, M. L., Gross, B. H., Chughtai, A. R., Sayyouh, M., Kazerooni, E. A., Bartholmai, B. J., Xia, M., Murray, S., Myers, J. L., Lagstein, A., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00443-2018 · Cited by 85
Self-citationPulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial Pneumonia
Omori, T., Tajiri, M., Baba, T., Ogura, T., Iwasawa, T., Okudela, K., Takemura, T., Oba, M. S., Maehara, T., Nakayama, H., et al. (2015) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2015.03.094 · Cited by 85
Metadata
- Authors
- Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., Lynch, D. A., Ryu, J. H., Swigris, J. J., Wells, A. U., Ancochea, J., Bouros, D., Carvalho, C., Costabel, U., Ebina, M., Hansell, D. M., Johkoh, T., Kim, D. S., King, T. E., Kondoh, Y., Myers, J., Müller, N. L., Nicholson, A. G., Richeldi, L., Selman, M., Dudden, R. F., Griss, B. S., Protzko, S. L., & Schünemann, H. J.
- Affiliations
- University of Washington (US)
- University of California, San Francisco (US)
- Mater Misericordiae University Hospital (IE)
- Ludwig-Maximilians-Universität München (DE)
- Mayo Clinic (US)
- University of Michigan (US)
- Tulane University (US)
- University of Colorado Boulder (US)
- National Jewish Health (US)
- Royal Brompton Hospital (GB)
- Hospital Universitario de La Princesa (ES)
- University Hospital of Alexandroupolis (GR)
- Universidade de São Paulo (BR)
- Tohoku University (JP)
- Royal Brompton & Harefield NHS Foundation Trust (GB)
- The University of Osaka (JP)
- University of Ulsan (KR)
- University of Modena and Reggio Emilia (IT)
- Instituto Nacional de Enfermedades Respiratorias (MX)
- ORCID
- Raghu, Ganesh
- Collard, Harold R.
- Colby, Thomas V.
- Lasky, Joseph A.
- Lynch, David A.
- Ryu, Jay H.
- Swigris, Jeffrey J.
- Wells, Athol U.
- Ancochea, Julio
- Bouros, Demosthenes
- Carvalho, Carlos
- Costabel, Ulrich
- Johkoh, Takeshi
- King, Talmadge E.
- Kondoh, Yasuhiro
- Myers, Jeffrey
- Nicholson, Andrew G.
- Richeldi, Luca
- Selman, Moisés
- Schünemann, Holger J.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03
- Volume
- 183
- Issue
- 6
- Pages
- 788-824
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC5450933
- OpenAlex
- W2167383172
- Cited by
- 7,186
- References
- 325
- Citations by year
- 2026: 187 · 2025: 307 · 2024: 436 · 2023: 432 · 2022: 522 · 2021: 640 · 2020: 607 · 2019: 596 · 2018: 607 · 2017: 605 · 2016: 569 · 2015: 531 · 2014: 426 · 2013: 370 · 2012: 256
- FWCI
- 304.18
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (K23HL092227)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, diagnosis, management, natural history (disease), staging, prognosis, risk factors, treatment, disease surveillance, GRADE
- MeSH terms
- Europe, Humans, International Cooperation, Japan, Latin America, Societies, Medical, United States, Evidence-Based Medicine, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.